Business Context and Reporting Period
CareTrust REIT, Inc. (NYSE: CTRE) filed a Form 8-K on February 17, 2026, reporting the entry into a new Material Definitive Agreement. The filing details the establishment of a new equity distribution program to raise capital for general corporate purposes.
Key Financial Metrics and Capital Structure
This filing does not report operational financial metrics such as revenue, profit, cash flow, or margins. The primary financial data relates to capital raising capacity:
- New Equity Program Capacity: Up to $1,000,000,000 in aggregate gross offering price under the "February 2026 ATM Program."
- Commission Rates: Sales agents and forward purchasers may receive commissions not exceeding 2.0% of the sale price or volume-weighted average price.
- Outstanding Forward Agreements: $367.0 million in shares subject to outstanding forward sale agreements from the prior program remain active.
- Unused Prior Program Capacity: Less than $10.0 million remained unsold under the terminated prior agreement.
Material Changes Versus Prior Period
The Company terminated its prior equity distribution agreement dated January 21, 2025, and replaced it with the new February 2026 ATM Program. While the prior program was terminated, existing forward sale agreements totaling $367.0 million under that program will remain outstanding and settle according to their original terms.
Guidance, Outlook, and Management Commentary
Management intends to contribute net proceeds from the new program to the Operating Partnership for general corporate purposes, including future acquisitions, debt repayment, and working capital. Proceeds may be temporarily invested in interest-bearing short-term investments consistent with REIT qualification. The filing notes that the Company may physically settle, cash settle, or net share settle forward sale agreements; cash or net share settlements may result in the Company owing cash or shares rather than receiving proceeds.
Investor Verification Checklist
- Verify the specific terms of the Master Forward Sale Agreements filed as Exhibit 1.1 to understand settlement obligations.
- Monitor the $367.0 million in outstanding forward sale agreements from the prior program for potential dilution upon settlement.
- Review the shelf registration statement (File No. 333-293536) for details on the issuance of shares under the new $1.0 billion program.
- Assess the impact of potential cash or net share settlements on the Company's liquidity and share count.